The covalent attachment of ubiquitin onto proteins can elicit a variety of downstream consequences. Attachment is mediated by a large array of E3 ubiquitin ligases, each thought be subject to regulatory control and to have a specific repertoire of substrates. Assessing the biological roles of ligases, and in particular, identifying their biologically relevant substrates has been a persistent yet challenging question. In this study, we describe tools that may help achieve both of these goals. We describe a strategy whereby the activity of a ubiquitin ligase has been enzymatically reversed, accomplished by fusing it to a catalytic domain of an exogenous deubiquitinating enzyme. We present a library of 72 "anti-ligases" that appear to work in a dominant-negative fashion to stabilize their cognate substrates against ubiquitin-dependent proteasomal and lysosomal degradation. We then used the ligase-deubiquitinating enzyme (DUb) library to screen for E3 ligases involved in post-Golgi/endosomal trafficking. We identify ligases previously implicated in these pathways (Rsp5 and Tul1), in addition to ligases previously localized to endosomes (Pib1 and Vps8). We also document an optimized workflow for isolating and analyzing the "ubiquitome" of yeast, which can be used with mass spectrometry to identify substrates perturbed by expression of particular ligase-DUb fusions.
percentage of any protein population. Furthermore, ubiquitinated substrates are prone to deubiquitination during cell lysis procedures, when an array of deubiquitinating enzymes, which are notoriously difficult to inactivate, are unleashed. 10 In vitro approaches have greatly aided our understanding of the ubiquitination process, but generally fall short in preserving the level of specificity, diversity and sensitivity needed to identify substrate candidates.
One of the best characterized E3 ligases in yeast is Rsp5, a HECT domain ligase of the NEDD4 (neural-precursor-cell-expressed, developmentally downregulated) ligase family, which has multiple cellular roles. 11 Rsp5 has been intensely studied and proved to be a useful model for understanding human disease, such as alpha-Synuclein trafficking 12 and mechanisms driving catalysis of the NEDD4 ligases. 13, 14 Although many putative ligases have no known substrates, Rsp5
has been implicated in the ubiquitination of approximately 80 substrates. [15] [16] [17] Rsp5 was originally identified as npi1 (nitrogen permease inactivator 1) because of its role in downregulating cell surface transporters, such as Gap1 and Fur4. 18, 19 Indeed, although Rsp5
has been shown to ubiquitinate proteasomal cargoes, 20 its broader function appears to be in modifying membrane proteins to provide a sorting signal for their delivery and degradation in the vacuole. Rsp5
is essential for viability owing to its role in controlling transcription of the enzyme required for oleic acid production. 21 Loss of function temperature-sensitive alleles have been useful tools to acutely inhibit Rsp5; however, different alleles appear to have varying levels of residual activity toward particular substrates. 22, 23 Previously, we used an alternative approach to inhibit the function of Rsp5 that involved fusing the catalytic domain of a deubiquitinating enzyme (DUb) to the C-terminus of the ligase 24 and place production of this fusion protein under an inducible promoter. This dominant-negative Rsp5-DUb antagonizes endogenous Rsp5, illustrated by stabilization of a host of Rsp5 substrates. 24 Here, we apply this principle more widely by creating a systematic plasmid library of ligase-DUb fusion proteins. A survey of some of these "anti-ligases" show that they antagonize the function of their endogenous counterpart, and do so with the sensitivity and specificity required to perform future functional studies. In addition, we use this panel of antiligases to implicate new ubiquitin-dependent roles for Tul1, Pib1 and Vps8 in the sorting of the soluble hydrolase carboxypeptidase Y (CPY) to the vacuole. Finally, we present optimized methods and a yeast strain for proteomic analysis of the ubiquitinated portion of the yeast proteome, or "ubiquitome". Our mass spectrometry analyses of purified FIGURE 1 A systematic plasmid library for reversal of yeast E3-ligase activity. A, Schematic representation of ligase-DUb fusion proteins. The final step in the ubiquitination cascade involves transfer of Ub from an E2 conjugating enzyme to a substrate through the activity of an E3 ligase enzyme. Substrate deubiquitination is induced by expression of E3 ligase-DUb fusion proteins. B, E3 ligases expressed in wild-type cells as fusions with a C-terminal DUb (UL36) enzyme and an Hemagglutinin (HA) epitope. A 50 μM copper was added to the media to induce protein expression from the CUP1 promoter. Two transformants for each ligase-DUb fusion were validated; a black asterisk indicates particular fusions for which only one Ura + clone expresses.
Molecular weight markers are indicated. DUb, deubiquitinating enzyme FIGURE 2 Phenotypic analyses of ligase-deubiquitinating enzyme (DUb) fusion library. A, Wild-type (SEY6210) yeast cells were grown to midlog phase in SC media lacking uracil, harvested and a 10-fold serial dilution was spotted out on plates containing different solid media. Cells were plated on media containing 50 μM bathocupriosulfonic acid (BCSA) to repress gene expression. Cells were also plated on media lacking copper or plasmid expression was induced on plates containing 50 μM copper chloride. These plates were incubated at 30 or 37 C. Cultures were also plated on copper containing media lacking glucose as a primary carbon source, which were instead supplied with oleate at 30 C and ethanol glycerol at 30 and 37 C. B, Wild-type yeast cells expressing labeled DUb fusions, or vector control, were grown to mid-log phase in standard SC-Ura media and prepared for immunoblot analysis using anti-HA and anti-Rsp5 antibodies. Cells were also grown to mid-log phase in minimal media and then labeled with MitoTracker for 1 hour, washed twice with water and then imaged by fluorescence microscopy. A Normarski image is included and 5 μm scale bars are indicated ubiquitinated species indicate many components of the post-Golgi trafficking machinery, including many Soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor (SNARE) proteins, that may use ubiquitination to regulate their trafficking function. Furthermore, we quantitatively measure changes in ubiquitome levels following expression of the Pib1-DUb antiligase, to demonstrate the potential this combination of approaches has toward deciphering the function of Ubligases.
| RESULTS AND DISCUSSION

| A systematic library of ligase-DUb fusion proteins
A chimera of Rsp5 and the deubiquitinting enzyme (DUb) UL36 from the Herpes simplex virus I creates a dominant negative "anti-ligase" fusion protein that specifically deubiquitinates Rsp5 substrates. 24 We FIGURE 3 Legend on next page.
hypothesized this strategy could be applied to make an array of tools to probe the molecular functions of other E3 ligases ( Figure 1A ). We To test whether particular DUb fusions elicit specific effects, we tested the ability of the ligase-DUbs to perturb cellular growth on their own or in combination with environmental stresses (Figure 2 ). Figure 2B ).
To directly demonstrate that a particular substrate could be targeted by its cognate ligase-DUb, we focused on 2 Rsp5 substrates, Sna3 and Cos5, that receive a ubiquitination signal that directs their sorting into the vacuolar lumen. 23, 26, 27 Both Sna3 and Figure 3D ). From this experiment, we found that the levels of ubiquitinated Sna3 and Cos5 were markedly depleted upon expression of the Rsp5-DUb antiligase ( Figure 3E ).
Collectively, these experiments show that each ligase-DUb fusion can be inducibly expressed by the addition of copper to the media and that they can elicit specific and potent phenotypes.
| Ligase-DUbs block degradation of substrates
We next tested whether other ligase-DUb fusions could specifically stabilize substrates, as we found for Rsp5-DUb 24 ( Figure 3 ). The ligase Hrd1 has a well-established role in ubiquitinating substrates for the ER-associated degradation (ERAD) pathway. 28, 29 A model misfolded ERAD substrate is CPY*, a mutant form of CPY expressed by the prc1-1 allele. 30 CPY* is ubiquitinated by Hrd1 at the ER and degraded by the proteasome. 6 We found inducing the expression of Substrate specific ligase reversal. A, Mutant prc1-1 (CPY*) cells expressing labeled ligase-DUb fusions were grown to mid-log phase before equivalent cells were harvested from each culture. Lysates were generated by treatment with 0.2 M NaOH, resuspension in Laemmli sample buffer containing 8 M urea, followed by Sodium dodecyl sulfate -Polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis using antibodies that recognize CPY*, PGK and Dpm1. Different exposures of α-HA immunoblots have been separated by spaces/ dotted lines. The steady state levels of CPY* were quantified by densitometry using Fiji software and normalized against loading control (right). Replicate number (n=) is indicated and the SD shown with error bars. B, prc1-1 cells transformed with vector, Hrd1-DUb and Roy1-DUb were grown to mid-log phase, treated with 200 μg/mL cycloheximide before samples were harvested for immunoblotting at 0, 30 and 60-minute time-points. Resolved lysates were probed with antibodies raised against HA, CPY* and PGK. The levels of CPY* were compared to the PGK loading control using densitometry and used to plot the degradation kinetics of CPY* over time, depicted in line graph (right). The SD from 3 experiments is shown with error bars. C, BY4741 cells stably expressing Cln2-TAP and expressing labeled ligase-DUb fusions from a plasmid were grown to mid-log phase an prepared for immunoblot analysis with anti-HA, anti-TAP, anti-CPY and anti-Rsp5 antibodies. Non-specific bands are labeled with an asterisk (*). Cln2-TAP levels were quantified as described in (A). CPY, carboxypeptidase Y; DUb, deubiquitinating enzyme Hrd1-DUb caused a dramatic accumulation of CPY* ( Figure 4A ). This effect was specific to CPY* because no accumulation was observed for Pgk1 or the ER resident Dpm1. In addition, expressing various other DUb fusions had no significant impact on the levels of CPY*.
We did note that addition of copper alone appears to decrease the levels of CPY*, although we did not pursue an explanation for this effect. Despite this effect of copper alone, it was clear that CPY* was greatly stabilized by Hrd1-DUb expression but not other ligase-DUbs ( Figure S2A ). Expression of Hrd1-DUb also specifically blocked degradation of CPY* following a cycloheximide chase period ( Figure 4B ), a commonly used method to assess ERAD substrate degradation. 31 The Grr1 ligase is known to target the cell cycle regulators Cln1 
| Ligases involved in post-Golgi membrane trafficking
We next used the library to screen for ligases that might be involved in endosomal membrane trafficking. We used 2 assays: first was a growth assay in media containing low tryptophan (Trp), which reveals a growth benefit to cells that can stabilize the high affinity tryptophan permease Tat2 at the cell surface. The second assay was secretion of the soluble vacuolar protease CPY, which serves as a general measure of proper sorting for many steps within the post-Golgi/ endosomal pathway. 35 For the Tat2 activity assay, we have previously documented that accelerated Multivesicular body (MVB) sorting of Tat2 results in a growth defect in low Trp, 27 and reasoned that any ligases that exert influence on the ubiquitination status of Tat2 showing that canavanine-sensitivity requires active deubiquitination FIGURE 6 Validation of ligases involved in the MVB sorting pathway. A, Wild-type cells transformed with vector control, Pib1-DUb or Tul1-DUb were grown to mid-log phase before equivalent volumes harvested and spotted out in serial dilution (1:9) on SD-Ura-Arg media containing 50 μM copper chloride and varying concentrations of canavanine (upper). Experiments were repeated on media containing Arginine (middle), including a control set in which a catalytically dead version of Pib1-dub* was expressed (lower). B, Cells transformed with either Ste3-GFP or Ste3-GFP-Ub alongside active and inactive versions of Pib1-DUb and Tul1-DUb were grown to mid-log phase before copper addition to induce expression of DUb-fusions. Cells were harvested and prepared for fluorescence microscopy after 2 hours. The 5 μm scale bars are indicated. DUb, deubiquitinating enzyme FIGURE 7 Screen for ligases involved in vacuolar sorting of soluble hydrolases. A, Schematic diagram of CPY trafficking, where newly synthesized CPY traffics to the Golgi, where it is modified to a p2-CPY precursor form (black dots) before trafficking to late endosomes, packaging into luminal vesicles at the MVB and sorting to the vacuole where it is processed to the final mature mCPY form (black circular sector). This sorting is defective in vacuolar protein sorting pathway (vps) mutants and p2-CPY is instead secreted from the cell. B, SEY6210 cells expressing both clones ( Figure 1B ) of the DUb-fusion library were grown in the presence of copper and overlaid with a nitrocellulose membrane. Levels of secreted CPY were assessed by immunobloting the membranes with anti-CPY antibodies. All experiments contained vector controls of wild-type cells, as a negative control, and vps4Δ cells, which secrete >40% CPY, as a positive control. C, Overlay experiments showing that pib1Δ and tul1Δ null cells do not secrete CPY, unlike vps4Δ and vps8Δ cells. However, expression of dominant antiligase versions of Pib1, Tul1 and Vps8 all secrete CPY, an effect that relies on the catalytic activity of the DUb fusion (dub* versions express a catalytically dead Cys > Ser mutant version). D, Expression of DUb fusions, and catalytically dead (dub*) versions, was assessed by immunoblot analysis of lysates generated from cells incubated in media containing copper for 2 hours. E, CPY secretion of wild-type, pib1Δ and tul1Δ cells transformed with an empty vector (left) or Rsp5-DUb (right) was assessed by immunoblotting the levels of CPY secreted onto an overlaid membrane during an overnight incubation. CPY, carboxypeptidase Y; DUb, deubiquitinating enzyme by Pib1-DUb. We also found that both Tul1-DUb and Pib1-DUb interrupted the normal delivery of Ste3-GFP along the MVB pathway into the lumen of the vacuole ( Figure 6B ), again consistent with the idea that each of these ligase-DUbs can target endosomal membrane proteins.
We next evaluated the ligase-DUbs for effects on the sorting of CPY to the vacuole ( Figure 7A ,B Our assay also showed that CPY was missorted upon expression of DUb-fused Vps8, a CORVET specific subunit that plays an essential role in the vesicle biogenesis process, alongside Vps3 and the core Class C subunits, which are also the main components of the HOPS complex that drives homotypic fusion of the vacuolar membrane. 44 Yet DUb fusions with other HOPS/CORVET components that also have the RING domain signatures of Ub-ligases (Vps11 and Vps18) did not cause CPY secretion ( Figure S3 ). This suggests that
Vps8 controls a Ub-dependent function when it is not in complex with other CORVET subunits.
In more general terms, our experiments uncover the existence of 1 or more Ub-dependent trafficking steps required for proper Tat2 trafficking and CPY sorting. Moreover, they implicate Pib1, Tul1 and Vps8 as ligases that contribute to this process. This is inferred from the dominant-negative effect that Pib1-DUb, Tul1-DUb and Vps8-DUb have on endosomal sorting. The idea that this is due to perturbation of a ubiquitination event is supported by the observation that expressing Pib1, Tul1 or Vps8 fused to a catalytically dead deubiquitinase domain has no effect on CPY secretion ( Figure 7C,D ). Figure S4A ). As loss of Vps8 itself causes CPY secretion, combining vps8Δ with other mutations would not have been informative. We did make alleles in which the C-terminal RING finger was deleted or altered in hopes of retaining the bulk of Vps8 function whilst removing its Ub-specific function.
However, these vps8 alleles did not complement CPY sorting , or by addition of 3% SDS to buffer (SDS). Manipulations were also compared following a 3-minute incubation in 0.2 N NaOH. All lysates were analysed by SDS-PAGE and Coomassie staining. B, Cells expressing His-HA-tagged ubiquitin were used to prepare lysates using the alkali and SDS method. Lysates were generated immediately () as in (B), or samples were treated with NaOH for 2 minutes (+) and an untreated control (−) prior to incubation in 50 mM NaN 3 for 30 minutes at room temperature. Lysates were then immunoblotted using anti-His tag and anti-PGK antibodies. C, Protein extraction methods were compared from 10, 100 and 1000 mL cultures, using anti-PGK, anti-CPY and anti-Dpm1 antibodies. The original lysates (Prep A) were stored in −20 C freezer and then analyzed alongside fresh lysates generated from cultures of the same volume (Prep B). An equivalent number of cells amongst the lysates generated from 10, 100 or 1000 mL cultures were analyzed. D, Whole-cell yeast lysates were generated using lysis buffer containing 3% SDS. SDS was then removed using centrifugal filtration devices (left) or by dialyzing against lysis buffer lacking SDS (right). Different protein amounts from each sample were analyzed by silver stain before (−) and after (+) detergent removal. E, Left, wild-type cells expressing different His-tagged ubiquitin constructs were analyzed by silver stain and immunoblot using anti-His antibodies. Different linker regions (none, 2, 4, 6 and 8 amino acids) between the His 6 -tag and Ubiquitin were compared. Right, cells expressing His-(no linker)-Ub and His-(8 amino acid linker: ALINQERA)-Ub cells were grown to mid-log phase and lysates were generated to compare original material. These lysates were then used to perform Ni 2+ -Nitrilotriacetic acid (NTA) affinity purifications, and the yield of protein for each transformant analyzed by silver staining and anti-His immunobloting. F, Schematic diagram of 2-step affinity purification of His-tagged ubiquitin. G, His-Ub conjugates were affinity purified from parental control yeast cells (lacking His-Ub) and cells expressing His-ALINQERA-Ub expressed from the CUP1 promoter. An additional sample was prepared from His-ALINQERA-Ub expressing cells that were treated with 20 mM MG-132 for 45 minutes prior to harvesting and extraction. A sample of the initial lysate was analyzed by silver stain and immunoblotting using anti-His antibodies. Purifications were performed using a 1-step protocol (see methods), that involved binding to a nickel column and elution using low pH buffer, or a 2-step protocol that involved neutralizing the initial elution, rebinding to Ni-NTA and eluting with imidazole. Immunoblot analysis of the 2-step protocol was also performed using anti-Ub antibodies FIGURE 9 Identification of ubiquitinated factors implicated in membrane trafficking. A, Scheme for integrating the TEF1*-6xHis-ALINQERA-Ub cassette in place of the endogenous UBI4 gene. B, Susceptibility of pdr5Δ ubi4Δ::TEF1*-6xHis-ALINQERA-Ub to the proteasome inhibitor MG132 and the protein translation inhibitor cycloheximide. Cells were grown in liquid culture in the presence of the indicated concentrations of MG132. Growth was monitored by OD 600 and plotted relative to that of wild-type cells grown in the absence of drug (upper). Cells were serially diluted and plated onto SD media or SD media containing 0.2 μg/mL cycloheximide (lower). C, Representative His-ALINQERA-Ub purification, with samples removed at each stage and prepared for analysis by silver stain and anti-His immunoblot. D, Affinity Ni 2+ -NTA purification of lysates generated from ubi4Δ pdr5Δ hbt1-CΔ yeast cells not expressing His-tagged proteins. Contaminant proteins that bind strongly to the nickel column were eluted, visualized by silver stain and then identified by mass spectrometry (listed in table below). E, Purifications of lysates generated from ubi4Δ pdr5Δ and ubi4Δ pdr5Δ hbt1-CΔ strains. The insert shows a zoomed in image of the purified Hbt1 band. F, Yeast cells expressing His-ALINQERA-Ub were treated with MG-132, with a control untreated sample, before lysates were generated and samples were prepared for tandem MS/MS analysis. Triplicate experiments were performed for each condition. The number of unique peptides identified for the initial directed MS run (dark grey) or following recursive analyses (light grey) is depicted. G, Proteins identified from analysis described in (F) were collated and differences following MG-132 treatment displayed as a Venn diagram (upper) and the change in protein levels following drug treatment shown (lower). Less than a 1.5-fold increase/decrease upon drug treatment was considered unaltered (grey).
substrates of their endogenous wild-type ligase counterpart. Several protocols have been described for isolating and quantifying ubiquitinated proteins by mass-spectrometry. However, we found that these had problems in maximizing yield and purity of the ubiquitome.
Therefore, we set out to optimize procedures for purifying pools of ubiquitinated proteins so that they could be easily compared to discover ligase-substrate relationships.
| A proteomic workflow for isolating and analyzing the ubiquitome
Optimizing the isolation of ubiquitinated proteins involved 3 main considerations: comprehensive cell lysis, a tight affinity tag for ubiquitinated proteins and a simple yet very selective affinity purification scheme for enrichment. These pools of ubiqutinated proteins would then be subjected to tryptic digestion and Liquid chromatographymass spectrometry (LC-MS/MS). We felt a highly purified fraction was critical to the overall strategy since designating whether a protein is ubiquitinated, and then quantifying its abundance, could rely on measuring any peptide of that protein rather than only peptides containing remnants of lysine ubiquitination (a di-Glycine "stump"
that remains attached to the ubiquitinated lysine after trypsin digestion). This strategy would cast a wider net for identifying ubiquitinated proteins that might not contain enough detectable di-glycine peptides for quantitation, or that may have a plethora of ubiquitination sites that do not accurately reflect what proportion of a protein pool is ubiquitinated.
For extraction, the treatment of cells with alkali (0.2 N sodium hydroxide) prior to SDS lysis 45 was the most efficient extraction method that also significantly reduced the deubiquitination of modified species when cells or non-denatured lysates are incubated without energy renewal ( Figure 8A ,B). As originally described, NaOH/SDS prepared lysates are typically performed on small volumes of yeast.
Because large quantities of lysates are required for downstream proteomic analysis, we confirmed that scaling up this procedure did not adversely affect reproducibility of extraction, as shown by immunoblotting the same amount amounts of lysates generated from 10 mL, 100 mL and 1000 mL cultures for marker proteins localized to the ER, cytosol and vacuole ( Figure 8C ). It was then crucial to remove SDS from samples so that they could be analyzed by LC-MS/MS. Previous methods describe a urea buffer exchange protocol using an ultrafiltration device. 46 Comparing this buffer exchange method with simple dialysis against urea buffer revealed dialysis removed SDS as quickly as centrifugal exchange, but with much less loss in overall protein levels ( Figure 8D ). This is an important consideration, as over 50% of sample was not recovered following buffer exchange. Considering, proteins of a certain size and/or hydrophobicity may be disproportionately lost during the removal of SDS, the landscape of the proteome could be significantly altered by not using dialysis, and it is therefore preferable to dialyze against large volumes of denaturing buffer. Even if proteins are depleted equally, this loss presents an unwieldy technical workflow to compensate.
We next focused on expression of 6xhistidine (His)-tagged Ub for capturing the ubiquitome. Procedures for isolating ubiquitinated proteins rely on expressing a 6xHis-tagged Ub in cells followed by affinity isolation of the 6xHis tag on Ni-NTA attached to sepharose. 47 Ni-NTA purification of 6xHis-ubiqutuinated proteins is advantageous because it can be done under denaturing conditions, specifically 8 M urea, which is the buffer into which our protein lysates are dialyzed.
During our initial optimization of different commercially available Ub
and His-tag antibodies it became apparent that anti-HisTag antibodies could not recognize 6xHis-Ub efficiently. Inserting a linker region of at least 6 or 8 amino acids was necessary to expose the epitope for immunodetection. Importantly, including this spacer also led to a considerable increase in the yield of purified ubiquitome, presumably by making the tag more accessible to the immobilized Ni-NTA ( Figure 8E ).
Using a single affinity isolation step to purify proteins on Ni-NTA sepharose was insufficient for eliminating non-specific proteins. This problem is exemplified by purifications from His-Ub expressing cells being indistinguishable from control cells lacking His-Ub, when assessed by silver staining of eluates. However, western blotting showed cells expressing His-Ub to be greatly enriched in ubiquitome. Matrix-assisted laser desorption/ionization -Time of flight (MALDI-TOF) identification of protein bands from Figure 9C , which were generated following affinity purification of parental strain ubi4Δ pdr5Δ hbt1-CΔ (not expressing His-tagged ubiquitin) on Ni 2+ -NTA agarose resin. Relevant identification information, abundance and histidine content is also included, which probably explain protein affinity to resin. Details of the Hbt1 are also included, although the hbt1-CΔ truncation successfully removes this contaminant from purifications and the protein was not detected on silver-stained gel processed for MALDI-TOF analysis.
We found that a 2-step purification almost entirely removed this non-specific background. Two-step purification of His-Ub was relatively simple, as the initial elution was performed at low pH, followed by neutralization, binding to a smaller bed volume, washing and imidazole elution, resulting in a much higher level of purification ( Figure 8F,G) . Indeed, the only remaining contaminants were identified as endogenous proteins that contain motifs mimicking His-tags, such as Snf1 that has 13 contiguous histidine residues in its Nterminal region and Hbt1 that contains multiple histidines within its C-terminal region ( Figure 9C ; Table 1 ).
We then built a yeast strain that expressed 6xHis-tagged Ub with an inserted 8 amino acid linker (6xHis-ALINQERA-Ub). Expression was from an engineered form of the TEF1 promoter that yields a moderate level of expression. 48 Rather than replace all endogenous
Ub genes with expression of 6xHis-Ub from a variable copy 2 μ plasmid, as has been done is some previous studies, we integrated our expression construct in cells with either all 4 of their Ub-encoding genes intact, or integrating our construct at the UBI4 locus to replace one of the main Ub-producing genes. We found that the loss of UBI4
increased the overall yield of ubiquitinated proteins 5-fold ( Figure 9A ). We also deleted the PDR5 gene, which encodes a broadspecificity efflux pump. This mutation sensitizes cells to drugs such as cycloheximide and increases the efficacy of the proteasomal inhibitor MG-132, which could be used in downstream experiments to accumulate proteasomal substrates ( Figure 9B ).
Of the endogenous protein contaminants following 2-step purification ( Figure 9C ), initial mass-spectrometry analysis of the ubiquitome fraction from these cells revealed that a major component was the contaminant protein Hbt1. This presented a significant problem because its abundance was so high that it interfered with the detection of other proteins within the sample. Hbt1 is a approximately 114 kDa protein that contains a C-terminal region with many tandem Histidine residues. Its ability to bind directly to Ni-NTA explains how it was found originally in studies looking for binding partners for Histagged Hub1. 49 It was also the only protein identified in all 4 experimental replicates in a recent mass spectrometry study isolating HisUb conjugates. 50 We sought to eliminate this contaminant to allow for a broader identification of peptides by mass spectrometry.
Although the function of Hbt1 is not clear, we found that deletion of HBT1 in the ubi4Δ pdr5Δ cells caused a growth defect (data not shown). As an alternative, we truncated the endogenous HBT1 ORF, removing the C-terminal portion containing the native poly-histidine tag (Table 1) while retaining the majority (residues 1-996) of the protein-coding region. This manipulation has no effect on growth.
Importantly, this eliminated the ability of Hbt1 to bind to Ni-NTA and removed it as a confounding contaminant in our ubiquitome samples ( Figure 9D ). Combining these approaches led to our final optimized purification protocol for affinity purifying the ubiquitome ( Figure 9E ).
To optimize the identification of ubiquitinated proteins by mass spectrometry, we found that recursive analyses performed on a modified exclusion list increased both the total number of proteins identified and the coverage of identified proteins ( Figure 9F ). This was done by subjecting a single sample to multiple rounds of LC-MS/MS using an Agilent 6520 Q-TOF instrument, and placing all of the successfully identified peptides on an exclusion list used to direct MS analysis in each subsequent round, as previously described. 51 This workflow was then used to perform 6 independent ubiquitome purifications, 3 under normal conditions and 3 in the presence of MG-132 to inhibit proteasomal degradation ( Figure 9G ), an approach that has been previously validated by mass spectrometry. 52 We identified almost 3000 proteins from these analyses. The relative levels of many of these were altered upon inhibition of the proteasome. Although not specifically targeted, this analysis also identified specific lysine residues containing a di-Gly stub, indicating some specific ubiquitination sites, some of which are novel; showing that the method enhancements described here will be useful for more detailed studies later. This analysis also highlighted several proteins that function in the endocytic pathway and could be targets of the Vps8-DUb, Pib1-DUb and/or Tul1-DUb proteins that cause endosomal sorting defects (Table 2 ). These include a large number of SNARE proteins (Table 3) List of vacuolar protein sorting (Vps) proteins and ubiquitnation sites identified from Figure 9G .
expression of Pib1-DUb, Tul1-DUb or Vps8-DUb and comparing changes within the ubiquitome upon their expression using the workflow described here should help narrow this candidate list. Intriguingly, although Rsp5 does not seem to be directly involved in the bulk of the ubiquitination required for these membrane trafficking steps, there was an additive effect of Rsp5-DUb in a pib1Δ background, suggesting that the function between the endosomal ligases is partially overlapping ( Figure 7E ).
The above described assays validate a role Rsp5 in endosomal ligase activity but suggest that other ligases, in particular Vps8, Pib1
and Tul1, collaborate to ubiquitinate components of the post-Golgi trafficking machinery, and this is required for upstream trafficking events, which subsequently converge with an Rsp5-dependent/MVB pathway. These additional ligases are all known to localize to endosomes and some have been reported to be active ligases. 38, 40, 53 The fact that, for example, pib1Δ cells do not have obvious sorting defects, 40 is in itself suggestive of a redundant role with another ligase.
| Alterations of the ubiquitome induced by Pib1-DUb
As a final exercise, we tested whether the ubiquitome isolation procedure was reproducible enough to examine the effects of ligaseDUb expression on the ubiquitome, using the Pib1-DUb antiligase as an example ( Figure 10A ). In order to assess changes in the ubiquitome it was tantamount to demonstrate that isolation of the ubiquitome, and subsequent analysis by LC-MS/MS, could yield reproducible results. This would be key so that changes induced by ligase-DUb expression could be reliably detected. For this evaluation we prepared biological replicates from 2 independent experiments from either control cells transformed with an empty vector or cells expressing Pib1-DUb ( Figure 10B ). Samples from cells lacking His-Ub were also analyzed to confirm efficient and specific purification of the ubiquitome. Tryptic fragments from ubiquitinated proteins were isolated before differential di-methyl labeling of amino groups using "light" and a "heavy" labels, as previously described 54 ( Figure 10C ).
Samples from vector control cells and Pib1-DUb-expressing cells were mixed at a 1:1 ratio and analyzed by LC-MS/MS using a Thermo
Orbitrap Fusion Lumos instrument, with triplicate injections for each sample. Unlike the MS procedures described in Figure 9 , this analysis did not employ additional chromatography steps before LC-MS/MS so as to simplify analysis and comparison of the replicate samples.
Peptides were identified, quantified and compared and are listed in Table S5 . Over all the samples, 587 proteins were identified, however, for quantitation, only proteins that were found in multiple injections across both replicates were used for analysis by MaxQuant. 55 Also we also found a subset of proteins that were only found in either the ubiquitomes from control cells or Pib1-DUb expressing cells ( Figure 10D ). We found that the levels of individual proteins within the ubiquitomes from 2 independent experiments were quite reproducible, for both control and Pib1-DUb samples ( Figure 10E ).
Interestingly, expression of Pib1-DUb caused a subset of proteins to be reproducibly reduced from the ubiquitome ( Figure 10F ). Perhaps the most relevant finding regarding the utility of the ubiquitome isolation procedure and its combination with ligase-DUb treatment is that the levels of a large majority of identified proteins within the ubiquitomes were unchanged, which supports the overall reproducibility of these techniques and speaks to the specificity of ligase- 
| SUMMARY
Here, we describe a new tool to study the function of E3 Ub-ligases:
a library expressing ligase-DUb "anti-ligases" that correspond to most of the known yeast Ub ligases, and which appear to largely function in a dominant negative manner. This tool complements a variety of other approaches to study ligase function that together make a more List of soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor (SNARE) proteins and ubiquitnation sites identified from Figure 9G . 
| MATERIALS AND METHODS
| Reagents
The plasmids, yeast strains and antibodies used in this study are listed in Tables S1-S3.
| Cell culture conditions
Standard rich Yeast extract peptone dextrose (YPD) and synesthetic complete (SC) media lacking appropriate base or amino acids were used throughout. Expression of plasmids under the control of the CUP1 promoter was induced by the addition of 50 μM copper chloride to the media. for further analysis, which was performed as described above with additional platings on very low Trp plates (2 μg/mL, 1.5 μg/mL, 1 μg/ mL, 0.5 μg/mL).
| CPY secretion assay
| Labeling of mitochondria
Yeast cells expressing labeled DUb fusion plasmids were grown to mid-log phase in SC-Ura media supplemented with either 2% glucose or 3% ethanol and 3% glycerol as a carbon source. Mitochondira staining was achieved by addition of 100 nM MitoTracker Red CMXRos dye to the cultures, which were grown at 30 C for 1 hour prior to washing with fresh media and imaging by fluorescence microscopy.
| Fluorescence microscopy
Yeast cells were grown to mid-log phase prior to resupension in "kill"
buffer containing 100 mM Tris-HCl (pH 8.0), 0.2% (w/v) NaN 3 and NaF, prior to fluorescence microscopy, performed as previously described. 27 
| Immunoblot
Yeast cells harvested at mid-log phase were subjected to alkali treatment (0.2 N NaOH) for 3 minutes followed by resuspension in 50 mM Tris-HCl (pH 6.8), 5% SDS, 10% glycerol and 8 M urea, to prepare whole cell lysates for SDS-PAGE. Immunoblotting was performed as previously described 23 using antibodies listed in Table S3 . search results with a <1% false discovery rate were accepted and converted to a scaffold file for data interpretation.
| Ubiquitome purification
| Recursive mass spectrometry analysis
| Dimethyl labeling of peptides
Samples were reduced with DTT, alkylated with chloroacetamide and then diluted for digestion first with Lys C and then Trypsin.
N-terminal amines and lysine residues were tagged using reductive amination with isotopic variants of formaldehyde, as previously described. 54 MALDI analysis of the total peptide content for each sample was then used to mix heavy and light samples at a 1:1 ratio.
| Comparative analysis of dimethyl-labeled peptides
The University of Iowa Proteomic Facility performed dimethyl labeling and analysis of peptides in Figure 10 . Each labeled ("light" and "heavy") peptide mixture was loaded on home-packed C-18 column (Halo 2.7 μm particles: MDC) 100 μm intradermal × 10 cm using the Thermo EZ nLC 1200 and analyzed on an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific). For each injection, an estimated 0.5 μg of total peptide was loaded and followed though a 120-minute linear gradient of 0% to 95% ACN in 0.1% formic acid. 
